- Home
- FSLR vs PODD Comparison
FSLR vs PODD Comparison
Compare FSLR & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSLR
- PODD
- Stock Information
- Founded
- FSLR 1999
- PODD 2000
- Country
- FSLR United States
- PODD United States
- Employees
- FSLR N/A
- PODD N/A
- Industry
- FSLR Semiconductors
- PODD Medical/Dental Instruments
- Sector
- FSLR Technology
- PODD Health Care
- Exchange
- FSLR Nasdaq
- PODD Nasdaq
- Market Cap
- FSLR 19.8B
- PODD 23.8B
- IPO Year
- FSLR 2006
- PODD 2007
- Fundamental
- Price
- FSLR $207.18
- PODD $342.31
- Analyst Decision
- FSLR Strong Buy
- PODD Strong Buy
- Analyst Count
- FSLR 26
- PODD 18
- Target Price
- FSLR $231.08
- PODD $334.50
- AVG Volume (30 Days)
- FSLR 2.8M
- PODD 532.2K
- Earning Date
- FSLR 10-28-2025
- PODD 11-06-2025
- Dividend Yield
- FSLR N/A
- PODD N/A
- EPS Growth
- FSLR 4.50
- PODD N/A
- EPS
- FSLR 11.70
- PODD 3.32
- Revenue
- FSLR $4,343,437,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- FSLR $28.05
- PODD $29.18
- Revenue Next Year
- FSLR $18.98
- PODD $18.09
- P/E Ratio
- FSLR $17.69
- PODD $102.63
- Revenue Growth
- FSLR 15.39
- PODD 26.00
- 52 Week Low
- FSLR $116.56
- PODD $225.37
- 52 Week High
- FSLR $262.72
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- FSLR 60.42
- PODD 52.53
- Support Level
- FSLR $196.80
- PODD N/A
- Resistance Level
- FSLR $209.13
- PODD $351.94
- Average True Range (ATR)
- FSLR 7.34
- PODD 7.66
- MACD
- FSLR -0.21
- PODD -14.02
- Stochastic Oscillator
- FSLR 76.30
- PODD 96.83
About FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.